These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The role of adjuvants in the efficacy of a peptide vaccine for myasthenia gravis. McAnally JL; Xu L; Villain M; Blalock JE Exp Biol Med (Maywood); 2001 Apr; 226(4):307-11. PubMed ID: 11368422 [TBL] [Abstract][Full Text] [Related]
24. Cross-reactivity and inhibition of haemolysis by polyclonal antibodies raised against St II, a cytolysin from the sea anemone Stichodactyla helianthus. Cristina Pico M; Basulto A; del Monte A; Hidalgo A; Eliana Lanio M; Alvarez C; Felicó E; Otero A Toxicon; 2004 Feb; 43(2):167-71. PubMed ID: 15019476 [TBL] [Abstract][Full Text] [Related]
25. CD4+ T and B cells cooperate in the immunoregulation of Experimental Autoimmune Myasthenia Gravis. Milani M; Ostlie N; Wu H; Wang W; Conti-Fine BM J Neuroimmunol; 2006 Oct; 179(1-2):152-62. PubMed ID: 16945426 [TBL] [Abstract][Full Text] [Related]
26. Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice. Mata E; Carcaboso AM; Hernández RM; Igartua M; Corradin G; Pedraz JL Vaccine; 2007 Jan; 25(5):877-85. PubMed ID: 17070628 [TBL] [Abstract][Full Text] [Related]
27. Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice. Quintilio W; Kubrusly FS; Iourtov D; Miyaki C; Sakauchi MA; Lúcio F; Dias Sde C; Takata CS; Miyaji EN; Higashi HG; Leite LC; Raw I Vaccine; 2009 Jun; 27(31):4219-24. PubMed ID: 19393709 [TBL] [Abstract][Full Text] [Related]
28. Mechanisms of action by immunologic adjuvants. Osebold JW J Am Vet Med Assoc; 1982 Nov; 181(10):983-7. PubMed ID: 6294032 [No Abstract] [Full Text] [Related]
29. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973 [TBL] [Abstract][Full Text] [Related]
30. Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice. Geurtsen J; Banus HA; Gremmer ER; Ferguson H; de la Fonteyne-Blankestijn LJ; Vermeulen JP; Dormans JA; Tommassen J; van der Ley P; Mooi FR; Vandebriel RJ Clin Vaccine Immunol; 2007 Jul; 14(7):821-9. PubMed ID: 17494641 [TBL] [Abstract][Full Text] [Related]
31. Suppression of IgE antibody formation in mice with nonspecific stimulation. Itaya T; Tomioka H; Kumagai A; Tada T Int Arch Allergy Appl Immunol; 1980; 62(4):389-96. PubMed ID: 7380577 [TBL] [Abstract][Full Text] [Related]
32. Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model. Ninomiya A; Imai M; Tashiro M; Odagiri T Vaccine; 2007 May; 25(18):3554-60. PubMed ID: 17293015 [TBL] [Abstract][Full Text] [Related]
33. Effect of adjuvants on the antibody response to a hapten on a thymus-independent carrier. Del Guercio P Nat New Biol; 1972 Aug; 238(85):213-5. PubMed ID: 4115393 [No Abstract] [Full Text] [Related]
34. Antibody response in silver catfish (Rhamdia quelen) immunized with a model antigen associated with different adjuvants. Pavan TR; Di Domenico J; Kirsten KS; Nied CO; Frandoloso R; Kreutz LC Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27464022 [TBL] [Abstract][Full Text] [Related]
35. The context of tetanus toxoid application influences the outcome of antigen-specific and self-directed humoral immune response. Stojanović M; Zivković I; Inić-Kanada A; Petrusić V; Mićić M; Dimitrijević L Microbiol Immunol; 2009 Feb; 53(2):89-100. PubMed ID: 19291092 [TBL] [Abstract][Full Text] [Related]
36. A peptide-based immunoassay for antibodies against botulinum neurotoxin A. Atassi MZ; Dolimbek BZ; Deitiker P; Jankovic J; Aoki KR J Mol Recognit; 2007; 20(1):15-21. PubMed ID: 16981247 [TBL] [Abstract][Full Text] [Related]
37. Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses. Lutsiak ME; Kwon GS; Samuel J J Pharm Pharmacol; 2006 Jun; 58(6):739-47. PubMed ID: 16734975 [TBL] [Abstract][Full Text] [Related]
38. The morphological response of lymphatic vessels to incomplete Freund adjuvant and typhoid-paratyphoid A and B vaccine. Jamison DG J Pathol; 1971 Dec; 105(4):291-4. PubMed ID: 5145720 [No Abstract] [Full Text] [Related]
39. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses. Chackerian B; Rangel M; Hunter Z; Peabody DS Vaccine; 2006 Sep; 24(37-39):6321-31. PubMed ID: 16806604 [TBL] [Abstract][Full Text] [Related]
40. Induction of graft-versus-leukemia (GVL) effect without graft-versus-host disease (GVHD) by pretransplant donor treatment with immunomodulators. Morecki S; Yacovlev E; Gelfand Y; Shabat Y; Slavin S Biol Blood Marrow Transplant; 2009 Apr; 15(4):406-15. PubMed ID: 19285627 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]